Equity

Non-Controlling Interests

HCA Healthcare Non-Controlling Interests increased by 2.5% to $3.26B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 6.6%, from $3.05B to $3.26B. Over 5 years (FY 2020 to FY 2025), Non-Controlling Interests shows an upward trend with a 7.0% CAGR.

Analysis

StatementBalance Sheet Statement
SectionEquity
CategoryOther
SignalContext dependent
VolatilityStable
First reportedQ4 2019
Last reportedQ4 2025

How to read this metric

Changes reflect the ownership structure of consolidated entities and the performance of those specific subsidiaries.

Detailed definition

Noncontrolling interests represent the portion of equity in a subsidiary that is not attributable, directly or indirectl...

Peer comparison

Common in companies with complex organizational structures or joint ventures.

Metric ID: noncontrolling_interests

Historical Data

19 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25
Value$2.38B$2.52B$2.42B$2.45B$2.54B$2.59B$2.69B$2.73B$2.76B$2.83B$2.83B$2.89B$2.94B$2.97B$3.05B$3.08B$3.16B$3.18B$3.26B
QoQ Change+5.7%-3.9%+1.0%+3.7%+2.1%+3.9%+1.2%+1.4%+2.5%+0.0%+1.8%+1.9%+1.0%+2.9%+0.9%+2.4%+0.6%+2.5%
YoY Change+6.5%+2.9%+11.2%+11.4%+8.9%+9.3%+5.2%+5.8%+6.3%+4.7%+7.8%+6.8%+7.4%+7.0%+6.6%
Range$2.38B$3.26B
CAGR+7.2%
Avg YoY Growth+7.2%
Median YoY Growth+6.8%
Current Streak16 quarters growth

Frequently Asked Questions

What is HCA Healthcare's non-controlling interests?
HCA Healthcare (HCA) reported non-controlling interests of $3.26B in Q4 2025.
How has HCA Healthcare's non-controlling interests changed year-over-year?
HCA Healthcare's non-controlling interests increased by 6.6% year-over-year, from $3.05B to $3.26B.
What is the long-term trend for HCA Healthcare's non-controlling interests?
Over 5 years (2020 to 2025), HCA Healthcare's non-controlling interests has grown at a 7.0% compound annual growth rate (CAGR), from $2.32B to $3.26B.
What does non-controlling interests mean?
The portion of a subsidiary's equity owned by outside parties.